Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOTENDO: 68Ga-DOTATOC PET/CT for Infective Endocarditis
NCT05183555Phase 2Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- May 2022
- Primary completion
- Jun 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of gallium Ga 68-edotreotide in infective endocarditis (IE), sponsored by CHRU de Nancy - Hôpital Central. Started May 2022; status: completed.
02
Drugs
gallium Ga 68-edotreotide
03
Conditions
infective endocarditis (IE)
Beyond the preview
Go deeper on NCT05183555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183555.